UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  June 22, 2016
 
 


CAS MEDICAL SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)
 


Delaware
(State or other jurisdiction
of incorporation)
0-13839
(Commission File Number)
06-1123096
(I.R.S. Employer
Identification No.)
 
 
44 East Industrial Road, Branford, Connecticut 06405
(Address of principal executive offices, including zip code)
 
 
(203) 488-6056
(Registrant's telephone number, including area code)
 

 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 

 
Item 5.07 Submission of Matters to a Vote of Security Holders.

At the annual meeting of stockholders of CAS Medical Systems, Inc. (the "Company") held on June 22, 2016, four proposals were voted upon and approved by the Company's stockholders.  A brief description of each proposal voted upon at the annual meeting and the number of votes cast for, against, and withheld, as well as the number of abstentions and broker non-votes, where applicable, are set forth below.

(1) Election of seven members of the Board of Directors, each for a term of one year:

Nominee
For
Withheld
Broker
 Non-Votes
Alan W. Milinazzo
19,475,801
454,614
10,099,246
Paul A. Molloy
19,925,815
   4,600
10,099,246
Thomas M. Patton
19,885,315
45,100
10,099,246
Gregory P. Rainey
19,917,815
12,600
10,099,246
James E. Thomas
19,914,115
16,300
10,099,246
Kathleen A. Tune
19,900,521
29,894
10,099,246
Kenneth R. Weisshaar
19,925,815
  4,600
10,099,246


(2) Approval of the 2011 Equity Incentive Plan, as amended:

For
Against
Abstain
Broker
Non-Votes
19,795,843
120,022
14,550
10,099,246
       


(3) Advisory approval of the compensation of the Company's named executive officers:

For
Against
Abstain
Broker
Non-Votes
19,822,997
100,818
6,600
10,099,246
       


(4) Ratification of the appointment of CohnReznick LLP as auditor for the Company for the fiscal year ending December 31, 2016:

For
Against
Abstain
 
29,954,209
73,952
1,500
 
       
 
 
 
 
 
 
2

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
 
  CAS MEDICAL SYSTEMS,  INC.  
 
 
 
 
   
Date:  June 23, 2016
By:
/s/ Jeffery A. Baird  
   
Jeffery A. Baird
 
    Chief Financial Officer  
       
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




3